| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/27/2013 | CN101917974B Method for lyophilising particles having a pharmaceutical compound contained therein and a pharmaceutical pack containing such particles |
| 03/27/2013 | CN101912615B Cladribine formulations for improved oral and transmucosal delivery |
| 03/27/2013 | CN101889993B Surface-modified salbutamol suspension type non-Freon inhalation aerosol and preparation method thereof |
| 03/27/2013 | CN101888848B Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same |
| 03/27/2013 | CN101854914B Stable formulations of amylin and analogues thereof |
| 03/27/2013 | CN101836987B Compound niacin sustained release tablet |
| 03/27/2013 | CN101829082B Method for preparing veterinary injection of spectinomycin hydrochloride and lincomycin hydrochloride |
| 03/27/2013 | CN101801322B Patch material |
| 03/27/2013 | CN101797241B Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol |
| 03/27/2013 | CN101784259B Antifungal composition |
| 03/27/2013 | CN101745027B Preparation method of xiaokeling condensed pill |
| 03/27/2013 | CN101744787B Controlled release composite containing vinpocetine |
| 03/27/2013 | CN101708189B Preparation method of carapax amydae extract for resisting liver fibrosis |
| 03/27/2013 | CN101686939B Nucleic acid microparticles for pulmonary delivery |
| 03/27/2013 | CN101637533B Application of Chinese medicinal composition in preparation of medicament for treating virus myocarditis |
| 03/27/2013 | CN101637530B Application of Chinese medicinal composition in preparation of medicament for treating urticaria |
| 03/27/2013 | CN101637529B Application of Chinese medicinal composition in preparation of medicament for treating hand-foot-and-mouth disease |
| 03/27/2013 | CN101632769B Chinese medicinal composition for regulating blood sugar and preparation method thereof |
| 03/27/2013 | CN101627996B Rabeprazole sodium composition and preparation method thereof |
| 03/27/2013 | CN101618117B Application of Chinese medicinal composition in preparing medicament for treating nephritis |
| 03/27/2013 | CN101612129B Nicotinylmethylamide freeze-dried powder preparation for injection and preparation method thereof |
| 03/27/2013 | CN101596146B Method for controlling temperature in the production process of seaweed polysaccharide plant empty capsules |
| 03/27/2013 | CN101564512B Quality control method of hyperthyroidism resistance powder |
| 03/27/2013 | CN101530506B Method for analyzing poisonous clear tablet |
| 03/27/2013 | CN101416955B Improved cataplasm ground-mass and use thereof |
| 03/27/2013 | CN101391073B Da huoluo capsule preparation method |
| 03/27/2013 | CN101381408B Cobratide extraction method, cobratide extracted thereby and formulation containing cobratide |
| 03/27/2013 | CN101348431B Method for producing low lead light density granular calcium citrate |
| 03/27/2013 | CN101346154B Water-soluble films comprising low-viscosity alginates |
| 03/27/2013 | CN101346134B Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing the polymers |
| 03/27/2013 | CN101282715B Method of storing nanoparticle formulations |
| 03/27/2013 | CN101252920B Stable fixed-dose unitary formulations containing tenofovir, a surfactant, efavirenz and emtricitabine |
| 03/27/2013 | CN101252914B Stable nanoparticle formulations |
| 03/27/2013 | CN101237854B Lipid construct for delivery of insulin to a mammal |
| 03/27/2013 | CN101217940B Glp-1类似物制剂 Glp-1 analog formulations |
| 03/27/2013 | CN101208018B Drink comprising a combination of fish oil and probiotics |
| 03/27/2013 | CN101194958B Method for preparing decocted ointment for treating headache |
| 03/27/2013 | CN101189016B Device and methods for treating paranasal sinus conditions |
| 03/27/2013 | CN101188996B Surface-modified microparticles and methods of forming and using the same |
| 03/27/2013 | CN101175404B Method and composition for use in preparation of a patient for surgery |
| 03/27/2013 | CN101146514B Drugs with improved hydrophobicity for incorporation in medical devices |
| 03/27/2013 | CN101119710B High concentration self-microemulsifying coenzyme Q10 preparations for nutritional use |
| 03/27/2013 | CN101083981B Flavonoid composition for treating oral diseases |
| 03/27/2013 | CN101014319B Liquid depot formulation |
| 03/26/2013 | US8404793 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 03/26/2013 | US8404765 Sterically hindered amines and use thereof as polymer stabilizers |
| 03/26/2013 | US8404751 Subunguicide, and method for treating onychomycosis |
| 03/26/2013 | US8404455 Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides |
| 03/26/2013 | US8404300 Drug releasing coatings for medical devices |
| 03/26/2013 | US8404281 Formulations |
| 03/26/2013 | US8404278 Polyimide microparticles |
| 03/26/2013 | US8404277 Matrix-type transdermal drug delivery system and preparation method thereof |
| 03/26/2013 | US8404276 Pulmonary delivery for levodopa |
| 03/26/2013 | US8404275 Combination tablet with chewable outer layer |
| 03/26/2013 | US8404274 Aseptic combination preparation |
| 03/26/2013 | US8404273 Wound care system and bactericidal methods and devices |
| 03/26/2013 | US8404271 Contact drug delivery system |
| 03/26/2013 | US8404269 Elongated member containing drug in biodegradable material |
| 03/26/2013 | US8404267 Producing eye insertable drug delivery agent; extruding active ingredient with polyvinyl alcohol free biodegradable polymer |
| 03/26/2013 | US8404266 Method for stabilization of S-nitrosoglutathione and composition prepared by the same |
| 03/26/2013 | US8404256 Biomaterial composite composition and method of use |
| 03/26/2013 | US8404255 System and method for transdermal drug delivery |
| 03/26/2013 | US8403915 Multi-opening reservoir devices for controlled release or exposure of reservoir contents |
| 03/26/2013 | US8403914 Medical device with an energy supply carrying a reservoir |
| 03/26/2013 | US8403907 Method for wirelessly monitoring implanted medical device |
| 03/26/2013 | CA2649895C Stable hydroalcoholic oral spray formulations and methods |
| 03/26/2013 | CA2565295C Steroid intraocular implants having an extended sustained release for a period of greater than 2 months |
| 03/26/2013 | CA2545752C Treatment and prevention of liver disease associated with parenteral nutrition (pn) |
| 03/26/2013 | CA2543847C Insecticide formulation |
| 03/26/2013 | CA2537820C Process for preparing water-soluble medicaments comprising complexation of forskolin in cyclodextrins |
| 03/26/2013 | CA2532626C Particles containing an active agent in the form of a co-precipitate |
| 03/26/2013 | CA2513773C Clindamycin phosphate foam |
| 03/26/2013 | CA2501294C Spheroids, preparation process and pharmaceutical compounds |
| 03/26/2013 | CA2500126C Polymer solution and dispersion and a process for the preparation thereof |
| 03/21/2013 | WO2013040556A1 Compositions of jasmonate compounds and methods of use |
| 03/21/2013 | WO2013040494A1 Smarttm solid oral dosage forms |
| 03/21/2013 | WO2013040457A1 Controlled dosing of clopidogrel with gastric acid inhibition therapies |
| 03/21/2013 | WO2013040447A2 Combination therapy with low dosage strength imiquimod and photodynamic therapy to treat actinic keratosis |
| 03/21/2013 | WO2013040417A1 Amphiphilic cationic polymers for the delivery of therapeutic agents |
| 03/21/2013 | WO2013040295A2 Divalent-metal coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation |
| 03/21/2013 | WO2013040187A1 Solid dispersion of poorly soluble compounds comprising crospovidone and at least one water-soluble polymer |
| 03/21/2013 | WO2013040120A1 Formulations of cyclopropanecarboxylic acid {2-(1s)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}-amidecelgene corporation state of incorporation:delaware |
| 03/21/2013 | WO2013039994A2 Apparatus, composition, and related methods for transdermal delivery of active ingredients |
| 03/21/2013 | WO2013039993A1 Bioresorbable drug delivery matrices based on cross-linked polysaccharides, dosage forms designed for delayed/controlled release |
| 03/21/2013 | WO2013039713A2 Positive pressure medical dressings with valve and kits containing same |
| 03/21/2013 | WO2013039706A1 Drug delivery systems and applications |
| 03/21/2013 | WO2013039350A2 Skin composition for external use containing ceramides |
| 03/21/2013 | WO2013039167A1 Pharmaceutical composition for inhalation |
| 03/21/2013 | WO2013038402A1 Vaginal danazol combined with non steroidal anti inflammatory drugs (nsaids) compositions |
| 03/21/2013 | WO2013038323A1 Taste masked pharmaceutical compositions of cefuroxime axetil |
| 03/21/2013 | WO2013038271A1 Fill formulations and capsules and method of use to avoid migration of fill into or through the shell |
| 03/21/2013 | WO2013038268A1 Tamper resistant immediate release formulations |
| 03/21/2013 | WO2013038267A1 Tamper resistant pharmaceutical formulations |
| 03/21/2013 | WO2013038195A2 Pharmaceutical nanoparticle compositions |
| 03/21/2013 | WO2013038137A1 Method of coating microneedle devices |
| 03/21/2013 | WO2013038122A1 Method of coating microneedle devices |
| 03/21/2013 | WO2013037905A1 Use of 3-(r)-[3-(2-methoxyphenylthio)-2-(s)-methylpropyl]amino-3,4-dihydro- 2h-1,5-benzoxathiepine for preventing and/or treating cardiotoxic effects caused by chemotherapy and/or radiation |
| 03/21/2013 | WO2013037708A1 A fast dissolving pharmaceutical composition |
| 03/21/2013 | WO2013037650A1 Compositions for oral administration to animals, production methods thereof and uses of same |
| 03/21/2013 | WO2013037566A1 Aqueous compositions comprising arbekacin |